No Data
No Data
In the fiscal year ending December 2024, VIS will promote mRNA-targeted small molecule drug discovery business and the creation of its own pipeline.
Veritas In Silico <130A> announced its fiscal results for the year ending December 2024 on the 13th. Business revenue decreased by 46.0% compared to the previous year to 0.194 billion yen, with an operating loss of 0.212 billion yen (compared to a profit of 0.037 billion yen in the previous term), an ordinary loss of 0.233 billion yen (compared to a profit of 0.035 billion yen in the previous term), and a net loss of 0.236 billion yen (compared to a profit of 0.033 billion yen in the previous term). In the company's mRNA-targeted small molecule drug discovery business, the drug discovery platform ibVIS(R) is being utilized, and TORAY INDS INC <3402>.
Fanpepp --- In the fiscal year ending December 2024, research and development will be advanced focusing on antibody-inducing peptide projects and functional peptides.
Fanpep Co., Ltd. <4881> announced its consolidated financial results for the fiscal year ending December 2024 on the 12th. Revenue was 0.006 billion yen (compared to 0 billion yen in the previous period), operating loss was 0.901 billion yen (compared to 0.994 billion yen in loss), ordinary loss was 0.896 billion yen (compared to 0.94 billion yen in loss), and net loss attributable to the Shareholder for the current period was 0.889 billion yen (compared to 0.933 billion yen in loss). In the antibody-inducing peptide project, the antibody-inducing peptide "FPP003" (target protein: IL-17A) is discussed.
The Nikkei average fell by 172 points, dropping for the first time in four days, with a stronger yen weighing down, but many Main Board stocks rose = 7 days before the market.
Seven days ago, the Nikkei average stock price fell by 172.88 yen compared to the previous day, reaching 38,893.65 yen, marking a decline for the first time in four days. The TOPIX (Tokyo Stock Price Index) dropped by 10.61 points to 2,741.59 points. With the backdrop of a stronger yen, selling was dominant from the morning, and at 9:27 AM, the price reached 38,753.20 yen, down 313.33 yen. Subsequently, there was a movement to buy on dips, which reduced the decline. In the Foreign Exchange market, the yen strengthened to below 151 yen per dollar at one point, but later returned to 151 yen.
Fuji HD, US, ETC (additional) Rating
Downgrade - Bearish Code Stock Name Brokerage Firm Previous Changed After----------------------------------------------------------------<2175>SMS Morgan S "Overweight" "Equal Weight" <6367>Dai Kin Macquarie "Outperform" "Neutral" Target Price Change Code Stock Name Brokerage Firm Previous Changed After-----------------------------------
List of conversion stocks (part 2) [List of stocks converting with Parabolic Signals]
○ List of stocks that have turned to Sell in the market Code Name Closing Price SAR Main Board ＜3696＞ Ceres 2695 3120 ＜3762＞ Techmato 24052584 ＜3835＞ eBASE 592639 ＜3854＞ Aile 25182674 ＜3861＞ Oji Holdings 606640 ＜3880＞ Daio Paper 846873 ＜3902＞ MDV 502532 ＜3916＞ DIT 2000214
List of cloud break stocks (Part 2) [Ichimoku Kinko Hyo - List of cloud break stocks]
○ List of stocks below the clouds market Code Stock name Close price Leading Span A Leading Span B Tokyo Main Board <1333> Maruha Nichiro 2937 2973.5 3035 <1662> Petroleum Resources 1090 1092.5 121 <1721> Comsys HD 3192 3268.75 3212.5 <1833> Okumura Corporation 3860 3870 4132.5 <1951> Exeo Group 1661 1744.25